Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Common Equity: 2022-2025

Historic Common Equity for NewGenIvf (NIVF) over the last 4 years, with Sep 2025 value amounting to $28,739.3 billion.

  • NewGenIvf's Common Equity was N/A to $28,739.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28,739.3 billion, marking a year-over-year change of. This contributed to the annual value of -$1.5 million for FY2024, which is 139.67% down from last year.
  • Latest data reveals that NewGenIvf reported Common Equity of $28,739.3 billion as of Q3 2025, which was up 326,986,262.97% from $8.8 million recorded in Q2 2025.
  • In the past 5 years, NewGenIvf's Common Equity ranged from a high of $28,739.3 billion in Q3 2025 and a low of -$1.5 million during Q4 2024.
  • Moreover, its 3-year median value for Common Equity was $6.3 million (2023), whereas its average is $7,184.8 billion.
  • As far as peak fluctuations go, NewGenIvf's Common Equity surged by 563.39% in 2023, and later tumbled by 139.67% in 2024.
  • NewGenIvf's Common Equity (MRQ) stood at $563,113 in 2022, then skyrocketed by 563.39% to $3.7 million in 2023, then crashed by 139.67% to -$1.5 million in 2024, then surged by 1,939,544,505.73% to $28,739.3 billion in 2025.
  • Its Common Equity was $28,739.3 billion in Q3 2025, compared to $8.8 million in Q2 2025 and -$1.5 million in Q4 2024.